CVL-354

DRUG2 trials

Sponsors

Cerevel Therapeutics, LLC

Conditions

Healthy ParticipantsOpioid Use Disorder

Phase 1

A Single and Multiple Ascending Dose Trial of CVL-354 in Healthy Participants

CompletedNCT05138653

Cerevel Therapeutics, LLCHealthy Participants

Start: 2021-10-18End: 2023-01-23Updated: 2024-11-26

Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opioid Receptors in Brain Following Oral Dosing

CompletedNCT05547542

Cerevel Therapeutics, LLCOpioid Use Disorder

Start: 2023-03-02End: 2024-08-06Updated: 2025-07-14